They’re Calling Him “The Most Hated Man in America” For Price Gouging AIDS Patients. But What He Did is Actually Pretty Standard for Big Pharma

Martin Shkreli, an ex-hedge fund manager now with Turing Pharmaceuticals, has outraged the nation by purchasing the rights to the drug Daraprim and instantly raising the price from $13.50 to $750 per pill, while it takes just $1 to make one. This is not the first pharmaceutical scheme to take [...]
Read Full Article →